Journal of Addiction Medicine

Papers
(The H4-Index of Journal of Addiction Medicine is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine92
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations67
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.67
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases55
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–201955
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language52
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations42
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study41
Implantable Cardioverter Defibrillator Placement to Permit Ongoing Methadone Treatment Despite QT Prolongation and Torsades de Pointes: A Case Report38
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report38
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial38
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder35
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes34
Treatment of Kratom Use Disorder With Methadone in an Opioid Treatment Program32
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals30
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease29
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review26
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study25
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions24
Complicating Factors Surrounding Concurrent Use of Kratom and a Novel 7-hydroxymitragynine Product Among a Participant Enrolled in a Kratom Clinical Trial23
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions23
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder23
0.13181805610657